Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Keiichi Enjyoji, Ph.D.

Co-Author

This page shows the publications co-authored by Keiichi Enjyoji and Simon Robson.
Connection Strength

4.037
  1. Deletion of cd39/entpd1 results in hepatic insulin resistance. Diabetes. 2008 Sep; 57(9):2311-20.
    View in: PubMed
    Score: 0.393
  2. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost. 2005 Apr; 31(2):217-33.
    View in: PubMed
    Score: 0.315
  3. Structural and functional characterization of engineered bifunctional fusion proteins of CD39 and CD73 ectonucleotidases. Am J Physiol Cell Physiol. 2021 01 01; 320(1):C15-C29.
    View in: PubMed
    Score: 0.231
  4. Selective deletion of ENTPD1/CD39 in macrophages exacerbates biliary fibrosis in a mouse model of sclerosing cholangitis. Purinergic Signal. 2019 09; 15(3):375-385.
    View in: PubMed
    Score: 0.211
  5. Complete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient mice. J Lipid Res. 2017 07; 58(7):1292-1305.
    View in: PubMed
    Score: 0.182
  6. Characterization of circulating microparticle-associated CD39 family ecto-nucleotidases in human plasma. Purinergic Signal. 2014 Dec; 10(4):611-8.
    View in: PubMed
    Score: 0.151
  7. Liver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemia. Purinergic Signal. 2011 Dec; 7(4):427-34.
    View in: PubMed
    Score: 0.121
  8. Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer. Purinergic Signal. 2011 Jun; 7(2):231-41.
    View in: PubMed
    Score: 0.119
  9. Variable impact of CD39 in experimental murine colitis. Dig Dis Sci. 2011 May; 56(5):1393-403.
    View in: PubMed
    Score: 0.115
  10. CD39/ENTPD1 expression by CD4+Foxp3+ regulatory T cells promotes hepatic metastatic tumor growth in mice. Gastroenterology. 2010 Sep; 139(3):1030-40.
    View in: PubMed
    Score: 0.113
  11. Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice. Hepatology. 2010 May; 51(5):1702-11.
    View in: PubMed
    Score: 0.112
  12. From the Cover: CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A. 2009 Sep 29; 106(39):16788-93.
    View in: PubMed
    Score: 0.107
  13. Preservation of cochlear function in Cd39 deficient mice. Hear Res. 2009 Jul; 253(1-2):77-82.
    View in: PubMed
    Score: 0.104
  14. Vascular smooth muscle cell expression of ectonucleotidase CD39 (ENTPD1) is required for neointimal formation in mice. Purinergic Signal. 2009 Sep; 5(3):335-42.
    View in: PubMed
    Score: 0.104
  15. Functional ENTPD1 polymorphisms in African Americans with diabetes and end-stage renal disease. Diabetes. 2009 Apr; 58(4):999-1006.
    View in: PubMed
    Score: 0.102
  16. Natural killer T cell dysfunction in CD39-null mice protects against concanavalin A-induced hepatitis. Hepatology. 2008 Sep; 48(3):841-52.
    View in: PubMed
    Score: 0.100
  17. Regulated catalysis of extracellular nucleotides by vascular CD39/ENTPD1 is required for liver regeneration. Gastroenterology. 2008 Nov; 135(5):1751-60.
    View in: PubMed
    Score: 0.099
  18. The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism. Front Biosci. 2008 Jan 01; 13:2588-603.
    View in: PubMed
    Score: 0.095
  19. Disordered pancreatic inflammatory responses and inhibition of fibrosis in CD39-null mice. Gastroenterology. 2008 Jan; 134(1):292-305.
    View in: PubMed
    Score: 0.094
  20. Disordered purinergic signaling inhibits pathological angiogenesis in cd39/Entpd1-null mice. Am J Pathol. 2007 Oct; 171(4):1395-404.
    View in: PubMed
    Score: 0.093
  21. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med. 2007 Jun 11; 204(6):1257-65.
    View in: PubMed
    Score: 0.091
  22. The vascular ectonucleotidase ENTPD1 is a novel renoprotective factor in diabetic nephropathy. Diabetes. 2007 Sep; 56(9):2371-9.
    View in: PubMed
    Score: 0.091
  23. Ecto-nucleotidases of the CD39/NTPDase family modulate platelet activation and thrombus formation: Potential as therapeutic targets. Blood Cells Mol Dis. 2006 Mar-Apr; 36(2):217-22.
    View in: PubMed
    Score: 0.084
  24. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury. Thromb Haemost. 2004 Mar; 91(3):576-86.
    View in: PubMed
    Score: 0.073
  25. Disordered cellular migration and angiogenesis in cd39-null mice. Circulation. 2001 Dec 18; 104(25):3109-15.
    View in: PubMed
    Score: 0.063
  26. Global deletion of NTPDase3 protects against diet-induced obesity by increasing basal energy metabolism. Metabolism. 2021 05; 118:154731.
    View in: PubMed
    Score: 0.059
  27. CD39/vascular ATP diphosphohydrolase modulates xenograft survival. Transplant Proc. 2000 Aug; 32(5):969.
    View in: PubMed
    Score: 0.057
  28. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection. Mol Med. 1999 Nov; 5(11):743-52.
    View in: PubMed
    Score: 0.054
  29. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med. 1999 Sep; 5(9):1010-7.
    View in: PubMed
    Score: 0.053
  30. HIF-1a-induced xenobiotic transporters promote Th17 responses in Crohn's disease. J Autoimmun. 2018 11; 94:122-133.
    View in: PubMed
    Score: 0.050
  31. Variation in glucose homeostasis traits associated with P2RX7 polymorphisms in mice and humans. J Clin Endocrinol Metab. 2015 May; 100(5):E688-96.
    View in: PubMed
    Score: 0.039
  32. NTPDase2 and purinergic signaling control progenitor cell proliferation in neurogenic niches of the adult mouse brain. Stem Cells. 2015 Jan; 33(1):253-64.
    View in: PubMed
    Score: 0.039
  33. CD39 improves survival in microbial sepsis by attenuating systemic inflammation. FASEB J. 2015 Jan; 29(1):25-36.
    View in: PubMed
    Score: 0.038
  34. Role of the ectonucleotidase NTPDase2 in taste bud function. Proc Natl Acad Sci U S A. 2013 Sep 03; 110(36):14789-94.
    View in: PubMed
    Score: 0.035
  35. P2X7 integrates PI3K/AKT and AMPK-PRAS40-mTOR signaling pathways to mediate tumor cell death. PLoS One. 2013; 8(4):e60184.
    View in: PubMed
    Score: 0.034
  36. Potential factors influencing the development of thrombocytopenia and consumptive coagulopathy after genetically modified pig liver xenotransplantation. Transpl Int. 2012 Aug; 25(8):882-96.
    View in: PubMed
    Score: 0.032
  37. Defective renal water handling in transgenic mice over-expressing human CD39/NTPDase1. Am J Physiol Renal Physiol. 2012 Aug 01; 303(3):F420-30.
    View in: PubMed
    Score: 0.032
  38. Tob1 is a constitutively expressed repressor of liver regeneration. J Exp Med. 2010 Jun 07; 207(6):1197-208.
    View in: PubMed
    Score: 0.028
  39. NTPDase1 governs P2X7-dependent functions in murine macrophages. Eur J Immunol. 2010 May; 40(5):1473-85.
    View in: PubMed
    Score: 0.028
  40. Tubuloglomerular feedback and renin secretion in NTPDase1/CD39-deficient mice. Am J Physiol Renal Physiol. 2008 Apr; 294(4):F965-70.
    View in: PubMed
    Score: 0.024
  41. The ectonucleotidase cd39/ENTPDase1 modulates purinergic-mediated microglial migration. Glia. 2008 Feb; 56(3):331-41.
    View in: PubMed
    Score: 0.024
  42. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors. J Exp Med. 2003 Sep 01; 198(5):783-96.
    View in: PubMed
    Score: 0.018
  43. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med. 2002 Apr; 8(4):358-65.
    View in: PubMed
    Score: 0.016
  44. Assignment of ecto-nucleoside triphosphate diphosphohydrolase-1/cd39 expression to microglia and vasculature of the brain. Eur J Neurosci. 2000 Dec; 12(12):4357-66.
    View in: PubMed
    Score: 0.015
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.